Welcome to Clearway Health - a recognized Great Place to Work® and destination organization! We are an award-winning culture where talented people are respected, informed, engaged, empowered, developed – and where they want to grow and make a difference. We offer a wide range of benefits, perks and wellness programs in addition to continuous learning opportunities to help you grow. At Clearway Health, diversity, equity, inclusion and belonging are an essential part of our business and workplace culture. Clearway Health emerged as a solution from Boston Medical Center to improve access to care, provide personal support and manage the complex specialty medication needs of vulnerable patients and their families. We partner with hospitals, health systems and the communities they care for to accelerate their specialty pharmacy programs. At Clearway Health, we take great pride in our High Five! Values to provide best in class experiences for our employees, our clients and their patients. We welcome you to follow us on LinkedIn where you can also learn more about our company, culture, people, and careers.
POSITION SUMMARY:
As a Senior Analyst, Pharmacy Finance, you will play a critical role in supporting Clearway Health Client Services by building and refining financial processes at client sites. You will work closely with Client Services leaders and the corporate finance team to provide specialized financial and accounting expertise tailored to pharmacy operations. In this capacity, you will help create and enhance client site P&Ls, analyze pharmacy-specific financials, and support strategic initiatives. Your work will combine robust data analysis with a client-focused approach to inform financial planning, forecasting, and reporting across our portfolio.
ESSENTIAL RESPONSIBILITIES/DUTIES:
EDUCATION:
CERTIFICATES, LICENSES, REGISTRATIONS REQUIRED:
EXPERIENCE:
KNOWLEDGE AND SKILLS:
Special Working Conditions (On-call, travel, shift, coverage):
MINDVERSE CONSULTING SERVICES
Wealthsimple
LifeStance Health
Just Global, Inc.
Forbes